Neurocrine Biosciences (NBIX) Non Operating Income: 2010-2021
Historic Non Operating Income for Neurocrine Biosciences (NBIX) over the last 12 years, with Sep 2021 value amounting to -$14.0 million.
- Neurocrine Biosciences' Non Operating Income fell 9.38% to -$14.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$36.4 million, marking a year-over-year decrease of 0.16%. This contributed to the annual value of -$25.7 million for FY2019, which is 70.99% down from last year.
- Latest data reveals that Neurocrine Biosciences reported Non Operating Income of -$14.0 million as of Q3 2021, which was down 164.15% from -$5.3 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Non Operating Income ranged from a high of $17.7 million in Q2 2019 and a low of -$31.7 million during Q3 2019.
- For the 3-year period, Neurocrine Biosciences' Non Operating Income averaged around -$7.6 million, with its median value being -$7.7 million (2019).
- In the last 5 years, Neurocrine Biosciences' Non Operating Income spiked by 535.85% in 2019 and then crashed by 1,150.00% in 2020.
- Neurocrine Biosciences' Non Operating Income (Quarterly) stood at -$4.9 million in 2017, then soared by 38.00% to -$3.1 million in 2018, then crashed by 231.08% to -$10.1 million in 2019, then soared by 59.62% to -$12.8 million in 2020, then dropped by 9.38% to -$14.0 million in 2021.
- Its Non Operating Income stands at -$14.0 million for Q3 2021, versus -$5.3 million for Q2 2021 and -$4.3 million for Q1 2021.